MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Svardal, A.
Right arrow Articles by Ueland, P. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Svardal, A.
Right arrow Articles by Ueland, P. M.

Disposition of homocysteine and S-3-deazaadenosylhomocysteine in cells exposed to 3-deazaadenosine

A Svardal, R Djurhuus and PM Ueland

The nucleoside analogue, 3-deazaadenosine (c3-Ado), serves both as a substrate and as an inhibitor of S-adenosylhomocysteine (AdoHcy) hydrolase, and the ability of this compound to induce accumulation of intracellular AdoHcy and S-3-deazaadenosylhomocysteine (c3-AdoHcy) in various cells and species has been widely documented. We here report on the effect of c3-Ado on the disposition of homocysteine (Hcy) and c3- AdoHcy in isolated rat hepatocytes and in non-transformed (Cl 8) and malignant (Cl 16) C3H/10T1/2 mouse embryo fibroblasts in culture. Both the liver cells and fibroblasts release large amounts of Hcy into the extracellular medium, whereas small amounts are retained within the cells. c3-Ado (100-300 microM) nearly completely inhibits cellular Hcy egress. Intracellular Hcy in liver cells exposed to c3-Ado is in fact increased in proportion to intracellular buildup of AdoHcy, whereas c3- Ado nearly deprives the malignant Cl 16 cells of intracellular Hcy and decreases it markedly in Cl 8 cells. Adenosine exerts a similar effect as c3-Ado on Hcy and AdoHcy in liver cells, but concentrations in the mM range are required, and the effect subsides within hours. In liver cells, c3-Ado(300 microm) induces a higher level of c3-AdoHcy than of AdoHcy. In the malignant (Cl 16) fibroblasts, c3-AdoHcy content approaches the amount of AdoHcy whereas, in the non-transformed (Cl 8) fibroblasts, relatively small amounts of c3-AdoHcy are formed. Notably, c3-AdoHcy is released from all cell types in proportion to the intracellular amount, suggesting that c3-AdoHcy is efficiently handled by the mechanism responsible for the cellular egress of nucleosidylhomocysteine. The possible role of Hcy and c3-AdoHcy in the mechanism of action of c3-Ado is discussed.

Volume 30, Issue 2, pp. 154-158, 08/01/1986
Copyright © 1986 by American Society for Pharmacology and Experimental Therapeutics







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1986 by the American Society for Pharmacology and Experimental Therapeutics